Matthew J. Gilroy

Matthew Gilroy is a partner in Weil’s Mergers & Acquisitions practice and is based in New York. Mr. Gilroy regularly represents acquirors, targets, boards of directors, special committees, investment banks and investors in complex domestic and cross border M&A in a broad range of industries, including for clients such as: Eli Lilly and Company; American International Group, Inc.; Leucadia National Corporation; Sanofi; Computershare, Inc.; Willis Towers Watson; Brookfield; Progressive Waste; Barclays; JPMorgan; and Centerview Partners.

Mr. Gilroy also counsels clients on a broad range of corporate, securities and business-related matters, including fiduciary duties, corporate governance, disclosure issues and compliance matters, as well as defensive measures, takeover tactics, proxy fights and other contests for corporate control.

Recent Experience:

• Transaction Committee of the Board of Directors of Reynolds American Inc. in Reynolds’ $60.6 billion sale to British American Tobacco p.l.c. (BAT) of the 57.8% of Reynolds stock that BAT did not already own.
• JAB Holding Company, as leader of an investment group, in that group’s $13.9 billion take-private of Keurig Green Mountain, Inc.
• Brookfield Asset Management Inc. and Brookfield Property Partners L.P. (BPY) in BPY’s $14.4 billion acquisition of the approximately 66% of common stock that it did not already own of GGP Inc. (f/k/a General Growth Properties Inc.).
• J.P. Morgan and Perella Weinberg, as financial advisors to AT&T Inc., in AT&T’s $108.7 billion acquisition of Time Warner Inc.
• Brookfield Asset Management Inc. in its $2.8 billion acquisition of all of the outstanding common shares not already owned by Brookfield Property Partners L.P. of Rouse Properties, Inc.
• Leucadia in its $3.7 billion merger with global investment banking firm Jefferies Group.
• Leucadia National Corporation in its acquisition of National Beef Packing Company for $868 million.
• Health Management Associates in its $7.6 billion sale to Community Health Systems.
• American Realty Capital Properties, Inc. in its approximately $700 million sale of Cole Capital to RCS Capital Corp.
• Cedar Fair, L.P. in its proposed $2.4 billion acquisition by an affiliate of Apollo Global Management.
• Irving Place Capital in its $412 million acquisition of Thermadyne Holdings Corporation.

Mr. Gilroy is also part of Weil’s Professional Evaluation & Compensation Committee and Philanthropic Committee, and has been active within the profession overall, having represented the Firm on the Corporations Law Committee of the New York City Bar.

Mr. Gilroy is a member of the Board of Visitors of the Georgetown University Law Center and Georgetown’s Corporate Counsel Institute.

Mr. Gilroy is also a member of the Board of Directors of New Alternatives for Children, a charitable organization that provides innovative high quality services in support of birth, foster and adoptive families caring primarily for medically fragile children.